Insulin resistance impairs insulins ability to suppress adipose tissue lipolysis Increased release of free fatty acids (FFAs) into circulation The liver accumulates fat due to: Excess FFA influx from adipose tissue Increased de novo lipogenesis (SREBP-1c, ChREBP activation) Reduced fatty acid oxidation and impaired autophagy Accumulation of FFAs and lipotoxic intermediates leads to: Mitochondrial dysfunction Oxidative stress (ROS generation) Activation of inflammatory pathways (JNK, NF-B) promotes: Cytokine release (TNF-, IL-6, TGF-) Hepatocyte injury and progression toward NASH Persistent inflammation activates hepatic stellate cells, resulting in: Fibrosis and progressive liver damage Clinical nutrition intervention directly targets key pathological drivers of fatty liver disease: Improving insulin sensitivity through structured medical nutrition therapy Reducing hepatic FFA load by modulating macronutrient quality and timing Limiting de novo lipogenesis via controlled carbohydrate quality and energy balance Supporting mitochondrial function and reducing oxidative stress Addressing gut-liver axis contributors such as endotoxemia Early, individualized dietary intervention can halt or reverse disease progression before irreversible liver damage occurs
As of 2024, over 2% of American adults are estimated to use GLP-1 medications for weight managementabout a six-fold increase in half a decade ( [22] )
Ozempic alternatives You cant get an injection site reaction if you dont have an injection site, and there are some alternatives that come as an oral medication instead of an injectable one
Minder EI, Barman-Aksoezen J, Schneider-Yin X
It mimics a naturally occurring hormone called glucagon-like peptide-1, which your gut releases after eating
doi: 10.1172/JCI146353 92 SvaneMSBojsen-MllerKNNielsenSJrgensenNBDirksenCBendtsenFet al
